BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

FAR Biotech

FAR Biotech logo

Website
http://www.farbiotech.com/
Founded
2016

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery Quantum Theory in Drug Discovery

Owner and operator of a biotechnology research company intended to accelerate drug discovery in areas with high unmet clinical need. The company's research services utilize proprietary quantum bio-chemistry platform to discover compounds that are active against novel, unrelated therapeutic targets associated with various cancers, neurodegeneration conditions and some rare and neglected diseases, enabling doctors to treat liver-stage malaria and African sleeping sickness.

Quantum biomodeling


Articles Mentioning This Company

14 Companies Using Quantum Theory For Drug Discovery (Including 2 Going Public)

14 Companies Using Quantum Theory To Accelerate Drug Discovery (Including 2 Going Public)

Feb. 24, 2024     Articles
(Updated: 24.02.2024) Molecular mechanics (MM) is a traditional computational approach when it comes to modeling in synthetic organic chemistry, medicinal chemistry, and versatile aspects of drug design. However, MM methods have significant limitations, for example, when used to study electron-based properties within the drug-receptor microenvironment. Quantum mechanical (QM) methods allow …

R&D Platform

FAR Biotech’s novel drug discovery technology blends existing empirical lab data with powerful machine learning algorithms to deliver a significantly faster discovery cycle at a fraction of the cost of typical drug development.

While most start-ups are typically single target ventures, FAR Biotech has developed a portfolio of diverse therapeutic targets and novel bio-active compounds that could be monetized on a stand-alone basis or as a pipeline.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.